Generic and Innovative Drugs Market in Russia and Ukraine 2011 - Comparative Analysis, Reimbursement Policies and Development Forecasts for 2011-2013

Date: March 22, 2011
Price:
US$ 2,130.00
Publisher: PMR
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: GD33CAD1FD4EN
Leaflet:

Download PDF Leaflet

Generic and Innovative Drugs Market in Russia and Ukraine 2011 - Comparative Analysis, Reimbursement Policies and Development Forecasts for 2011-2013
Single user licence: - US$ 2,130.00
5-user licence: - US$ 3,200.00
Corporate licence: - US$ 4,260.00
Global licence: - US$ 5,325.00


Generic and innovative drugs market in Russia and Ukraine 2011 is the first separate edition of a report providing a comprehensive study of recent trends, developments and forecasts in the generic and innovative drugs market in Russia and Ukraine. The report provides a comparative analysis of generic and innovative drugs segments in both countries and analyses the factors influencing the development of the market including its pricing and reimbursement policies, regulations on reimbursed and non-reimbursed medicines, patient and doctor attitude towards generic and innovative drugs and expected future changes in the generic and innovative drug market.

Counterfeit medicines in Russia and Ukraine are characterised in terms of their market share and government policies in both countries. The report addresses key questions such as the types of pharmaceutical companies likely to invest in drug manufacturing in Russia and considers the largest companies involved in clinical trials operation in Russia and Ukraine.

The report provides development forecasts up to 2013 and growth opportunities outlining the current and forecast value of the market as a whole and its segments together with their market share. In addition to the latest market data, profiles of the largest generic and innovative drug manufacturers are included alongside the best selling generic and innovative drugs in Russia and Ukraine.

Key Highlights:
  • Complete market data
  • Development forecasts for 2011-2013
  • Comparative market analysis of Russia and Ukraine
  • Market segment analysis
  • Key industry issues (pricing and reimbursement policies, Pharma 2020 programme, patients and doctors attitudes and regulatory industry changes)
  • Prospects for growth and investment
  • Profiles of the leading drug manufacturers in Russia and Ukraine
I. REPORT METHODOLOGY P.

II. EXECUTIVE SUMMARY P.

III. CHARACTERISTICS OF GENERIC AND INNOVATIVE DRUG MARKETS IN RUSSIA AND UKRAINE P.

Comparative analysis p.
Russia p.
Ukraine p.

IV. BEST-SELLING DRUGS IN RUSSIA AND UKRAINE P.

Russia p.
Ukraine p.

V. DRUG PATENT EXPIRY AND DATA EXCLUSIVITY PERIODS IN RUSSIA AND UKRAINE P.

Russia p.
Ukraine p.

VI. COUNTERFEIT MEDICINES IN RUSSIA AND UKRAINE P.

Russia p.
Ukraine p.

VII. REIMBURSEMENT AND PRICING POLICIES IN RUSSIA AND UKRAINE P.

Russia p.
Ukraine p.

VIII. KEY MANUFACTURERS IN RUSSIA AND UKRAINE P.

Profiles of selected leading innovative drug manufacturers p.
Profiles of selected leading generic drug manufacturers p.
Key players in Russia p.
Key players in Ukraine p.
Skip to top


Ask Your Question

Generic and Innovative Drugs Market in Russia and Ukraine 2011 - Comparative Analysis, Reimbursement Policies and Development Forecasts for 2011-2013
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: